Publications by authors named "Matteo Pio Vaira"
Article Synopsis
- Long-term right ventricular pacing (VP) can lead to negative outcomes like heart failure and cardiovascular mortality in patients who have undergone transcatheter aortic valve replacement (TAVR).
- The PACE-TAVI registry studied 377 TAVR patients with pacemakers, comparing those with VP below 40% to those at or above 40% to see how this affects their health outcomes.
- Results showed that patients with VP ≥40% had a significantly higher risk of cardiovascular death and heart failure hospitalization, emphasizing the need for closer monitoring of these patients after TAVR.
Colchicine, a microtubule-disassembling (antitubulin) agent used for centuries for the treatment of gout and autoimmune diseases, is a drug of growing interest in the cardiovascular field. While in the last decades it has become cornerstone of pericarditis treatment, it has also emerged in the last few years as a promising drug in the management of coronary artery disease, atrial fibrillation and heart failure. This systematic review and meta-analysis aimed to assess the efficacy of colchicine in patients with cardiovascular diseases.
View Article and Find Full Text PDFPredictors of pacemaker implantation after transcatheter aortic valve implantation according to kind of prosthesis and risk profile: a systematic review and contemporary meta-analysis.
Eur Heart J Qual Care Clin Outcomes
March 2021
Aims: Permanent pacemaker implantation (PPI) may be required after transcatheter aortic valve implantation (TAVI). Evidence on PPI prediction has largely been gathered from high-risk patients receiving first-generation valve implants. We undertook a meta-analysis of the existing literature to examine the incidence and predictors of PPI after TAVI according to generation of valve, valve type, and surgical risk.
View Article and Find Full Text PDF